You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Invitae said YouScript and Genelex will enable it to provide pharmacogenomic testing, while Diploid will help interpret WGS results.
After pilot programs showed patients and physicians are interested in genomics, NorthShore is working on "hardwiring" genetics into routine care.
The companies have agreed to combine their respective offerings into a single services package for drug target identification and validation.
The multi-omics translational software developer is helping the Crohn's & Colitis Foundation validate its research into biomarkers that can predict complications requiring surgery.
The computer technology firms will provide BGI Genomics with computational equipment and expertise to support its studies into the genomics of the virus.
Bioinformatics firm Next Gen Diagnostics will integrate Fluidigm's Juno microfluidic sample prep system into its workflow for pathogen whole-genome sequencing.
Researchers will use the VCurePrecision EMR platform to improve understanding of cancer, and doctors can use it make care decisions for patients.
Multi-omics approaches can give insight into the gut microbiome and more, but there are still challenges to address, speakers at the ABRF meeting said.
The company trimmed its net loss fell by three-fourths to $11.8 million in the quarter as it continues to rein in costs.
The method could prove useful for applications like single-cell proteomics where datasets often have small numbers of high-quality peptide identifications.
The partners will use Medidata's machine learning-based biomarker discovery platform to investigate the amyotrophic lateral sclerosis disease process.
Founded by former Inteliquet CEO Carla Balch, the firm is building on visualization technology to help physicians incorporate MDx testing into their practice.
The deal will allow users of MGI's DNBSEQ sequencers to convert previously validated assays to the platform and access Sophia's analytics technology.
With the partnership, the companies aim to help researchers streamline their workflows from sample collection to enrichment to interpretation.
The Cambridge, Massachusetts-based firm also said it tacked on $3 million to its Series B financing round for a total of $30 million.
With EMR upgrades, Penn and Rush now have structured genomic data informing clinical decision support in their precision oncology programs, but much work remains.
The company plans to offer four new products by the end of the year, including four targeted transcriptomic panels and IHC compatibility for Visium.
The companies will join their respective technologies to provide pharmacogenomic information for patients undergoing genetic testing.
The research-use-only workflow combines UgenTec's flagship FastFinder PCR diagnostics software platform and LGC Biosearch Technologies' reagents.
The methods exploit a feature of Oxford Nanopore's technology that ejects molecules mid-read, enabling a new level of control over human DNA sequencing runs.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.